UNSPSC 51101677: Sodium stibogluconate

This classification denotes an enzyme inhibitor and antiparasitic agent with the molecular formula C12H18O17Sb2.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V083S0159D, chemically known as trinatrium bis(gluconato(3)-o2,o3,o4)hydroxooxido-oxy-bis-antimonat(v) but generally known as sodium stibogluconate, which bears US NIH Compound Identifier 16683012. European Medicines Agency schedules Sodium stibogluconate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04492MIG.

UNSPSC 51101677 Sodium stibogluconate is a Commodity code that classifies pharmaceutical active ingredients and finished-form medicines procured by state and local health agencies. Recent state and local solicitations under this code show purchasing of prescription antibiotics and opioid-reversal medications, though the actual pharmaceutical products being bought—Doxycycline Hyclate, Ciprofloxacin Hydrochloride, and Naloxone—represent a broader pharmaceutical procurement scope than the code name alone suggests. State health departments and county health authorities are the primary issuing bodies, typically using piggyback cooperative purchasing contracts and competitive invitation-for-bid processes to source these products at volume pricing.

Activity in this code is concentrated in the Southeast and Midwest. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for antibiotic tablets with a 12-month initial term and renewal options. Seminole County, Florida issued an IFB in June 2026 for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries, requiring electronic bid submission and E-Verify compliance. Both opportunities specify fixed-fee pricing structures and multi-year contract terms with renewal or extension options, typical of state and local pharmaceutical procurement vehicles.